Related Experiment Video
Updated: Jul 1, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Left Ventricular and Right Ventricular Hypertrophy Modelling to Study PAPP-A-Mediated IGFBP-4 Cleavage-a Mechanism
Marina M Artemieva1, Arina V Makeeva1, Daria A Adasheva1
1School of Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
Pathological cardiac hypertrophy involves enlarged heart chambers. This study found that Pregnancy-associated plasma protein-A (PAPP-A) activity, which increases insulin-like growth factor (IGF) availability, was elevated in right ventricular hypertrophy (RVH) but not left ventricular hypertrophy (LVH).
Area of Science:
- Cardiovascular Research
- Molecular Cardiology
- Endocrinology
Background:
- Pathological cardiac hypertrophy, a precursor to heart failure, is characterized by abnormal enlargement of heart chambers.
- Right ventricular (RV) hypertrophy shows greater resistance compared to left ventricular (LV) hypertrophy.
- Insulin-like growth factors (IGFs) are crucial for cell growth and possess cardioprotective properties.
Purpose of the Study:
- To investigate the role of Pregnancy-associated plasma protein-A (PAPP-A) in regulating IGF bioavailability via IGF binding protein-4 (IGFBP-4) proteolysis in rat models of RV and LV hypertrophy.
- To explore potential differential mechanisms of IGF regulation between RVH and LVH.
Main Methods:
- Right ventricular hypertrophy (RVH) induced by monocrotaline and left ventricular hypertrophy (LVH) induced by the 1 Kidney 1 Clip (1K1C) model in rats.
- Assessment of cardiac chamber masses via heart morphometry and systolic blood pressure via tail-cuff plethysmography.
- Quantification of plasma B-type natriuretic peptide (BNP) and C-terminal IGFBP-4 (CT-IGFBP-4) using fluoroimmunoassay.
Main Results:
- Both RVH and LVH models were successfully established, showing significant increases in RV and LV masses, respectively.
- Plasma BNP levels were elevated in LVH, and hypertrophied cardiomyocytes secreted significantly more BNP in both RVH and LVH models.
- PAPP-A-mediated IGFBP-4 proteolysis was significantly elevated (4-fold) in RVH but remained unchanged in LVH compared to controls.
Conclusions:
- PAPP-A-driven IGFBP-4 proteolysis is predominantly elevated in RVH, suggesting differential IGF bioavailability between the ventricles.
- These findings highlight PAPP-A as a potential therapeutic target to enhance resistance to RV hypertrophy.
- The study elucidates a specific molecular mechanism contributing to the differing responses of the right and left ventricles to pathological stress.
More Related Videos
06:47A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Related Concept Videos
Heart Failure II: Pathophysiology
Cellular Adaptation II: Hypertrophy